Kingdon Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-65,100
Closed -$257K 115
2016
Q4
$257K Sell
65,100
-1,140,200
-95% -$8.35M 0.01% 122
2016
Q3
$12.6M Buy
1,205,300
+405,300
+51% +$5.83M 0.58% 46
2016
Q2
$11.7M Buy
+800,000
New +$13.7M 0.64% 47
2016
Q1
Sell
-400,000
Closed -$9.66M 116
2015
Q4
$9.66M Buy
+400,000
New +$10M 0.47% 60

Other funds holding DVAX

Kingdon Capital Management's DVAX Position: Q4 2016 in Review

Kingdon Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2016, closing a stake of 571,555 shares — an estimated $4.19M sold.

Kingdon Capital Management first reported a position in DVAX in Q2 2013 and held it in 11 quarters. The position peaked at $12.3M in Q2 2016. 111 funds tracked by Wall St. Rank hold DVAX as of Q4 2016.

  • Kingdon Capital Management reported no remaining Dynavax Technologies position as of Q4 2016 after selling out during the quarter.
  • Kingdon Capital Management sold 571,555 Dynavax Technologies shares in Q4 2016, an estimated $4.19M.
  • Kingdon Capital Management first reported a position in Dynavax Technologies in Q2 2013 and held it in 11 quarters.
  • Kingdon Capital Management's Dynavax Technologies position peaked at $12.3M in Q2 2016.
  • 111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2016.

Based on Kingdon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.